Exploring the viability of Zeatin as a prospective therapeutic candidate for investigating the complex interplay between severe acute respiratory syndrome coronavirus (SARS-CoV) and Alzheimer’s disease

被引:0
|
作者
A. S. Sriranjini
Ashish Thapliyal
Kumud Pant
机构
[1] Graphic Era Deemed to be University,Department of Biotechnology
关键词
SARS-CoV; COVID; Alzheimer’s; Pharmacology; APOE4; ACE2; SPIKE;
D O I
10.1007/s40203-024-00195-3
中图分类号
学科分类号
摘要
The present research aims to explore the intricate link between SARS-CoV infection and susceptibility to Alzheimer’s disease, focusing on the role of APOE4, a genetic factor associated with both conditions. Our research aims to uncover shared molecular pathways, considering APOE4’s impact on lipid metabolism, immune responses, and neuroinflammation relevant to COVID-19 and AD. The Chyawanprash phytocompounds were subjected to in-silico ADMET profiling and Zeatin a neuroprotective cytokinin emerged as a promising regulator of the ACE2-SPIKE complex as it exhibits favourable pharmacological attributes, presenting as a non-substrate for Permeability glycoprotein, low Protein Binding Percentage, and distinctive toxicity endpoints. Therapeutic candidate. Zeatin’s robust binding disrupts the intricate APOE4-ACE2-SPIKE interplay (AAS), offering a potential therapeutic avenue that is further corroborated by Molecular dynamic simulation as the system remained stable without any major fluctuation throughout the 100ns simulation. The AAS binding free energy, determined as -124.849 +/- 15.513 KJ/mol using MMPBSA assay, reveals significant contributions to complex stability from amino acids including, GLN41: 1.211 kcal/mol, GLU340: 1.188 kcal/mol, ALA344: 1.198 kcal/mol, while ARG38: 2.011 kcal/mol establishes pivotal strong bonds integral to the interaction between AAS and Zeatin. Rigorous cytotoxicity assessments reveal Zeatin’s safety profile, highlighting its inhibitory effect on LN18 cell viability that sharply decreases to 32.47% at 200 µg/ml, underscoring its modulatory impact on cellular metabolism. These findings enhance our understanding of the convergent mechanisms linking SARS-CoV and AD, providing valuable insights for potential therapeutic interventions. Further research is warranted to elucidate the specific pathways and molecular mechanisms through which zeatin exerts its protective effects.
引用
收藏
相关论文
共 50 条
  • [21] Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV)
    He, Zhongping
    Zhuang, Hui
    Zhao, Chunhui
    Dong, Qingming
    Peng, Guoai
    Dwyer, Dominic E.
    VIROLOGY JOURNAL, 2007, 4 (1)
  • [22] Diagnostics of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid antigen using chicken immunoglobulin Y
    Palaniyappan, A.
    Das, D.
    Kammila, S.
    Suresh, M. R.
    Sunwoo, H. H.
    POULTRY SCIENCE, 2012, 91 (03) : 636 - 642
  • [23] Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry
    Simmons, G
    Reeves, JD
    Rennekamp, AJ
    Amberg, SM
    Piefer, AJ
    Bates, P
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (12) : 4240 - 4245
  • [24] Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV)
    Zhongping He
    Hui Zhuang
    Chunhui Zhao
    Qingming Dong
    Guoai Peng
    Dominic E Dwyer
    Virology Journal, 4
  • [25] Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein
    Sainz, Bruno, Jr.
    Mossel, Eric C.
    Gallaher, William R.
    Wimley, William C.
    Peters, C. J.
    Wilson, Russell B.
    Garry, Robert F.
    VIRUS RESEARCH, 2006, 120 (1-2) : 146 - 155
  • [26] Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
    Liu, Ye V.
    Massare, Michael J.
    Barnard, Dale L.
    Kort, Thomas
    Nathan, Margret
    Wang, Lei
    Smith, Gale
    VACCINE, 2011, 29 (38) : 6606 - 6613
  • [27] Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting
    Abdirizak, Fatima
    Lewis, Rayleen
    Chowell, Gerardo
    THEORETICAL BIOLOGY AND MEDICAL MODELLING, 2019, 16 (01)
  • [28] Investigating a Role for Eosinophils in the Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Snow-Smith, Maryonne
    Baker, Paul J.
    Bohrer, Andrea C.
    Castro, Ehydel
    Torres-Juarez, Flor
    Anderson, Charles F.
    Makiya, Michelle M.
    Sereti, Irini
    Klion, Amy D.
    Mayer-Barber, Katrin D.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [29] Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2)
    To, KF
    Lo, AW
    JOURNAL OF PATHOLOGY, 2004, 203 (03): : 740 - 743
  • [30] Is There an Association Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Streptococcus pneumoniae?
    Howard, Leigh M.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (05) : E76 - E78